Aveanna Healthcare Reports Record Q2 Earnings for FY 2023

August 21, 2023

🌥️Earnings Overview

On August 10 2023, AVEANNA HEALTHCARE ($NASDAQ:AVAH) announced their second quarter of the 2023 fiscal year earnings (ending June 30 2023). Total revenue for the quarter was USD 471.9 million, a 6.5% increase compared to the same period in the previous year. Net income for the quarter grew by 105.4%, reaching USD 25.6 million.

Market Price

Aveanna Healthcare, a leading provider of pediatric home care services, reported record Q2 earnings for the fiscal year 2023 on Thursday. The company saw its stock open at $1.7 and close at $1.8, up by 3.4% from the previous closing price of $1.8. The strong numbers come as the demand for home care services is increasing greatly due to a growing aging population in need of in-home care and more families looking to keep their loved ones close and safe. Aveanna has been able to capitalize on this trend and provide high-quality care to its patients.

In addition, the company has seen an increase in revenues due to a rise in insurance coverage for home care services. This increased coverage has allowed more individuals to access the care that they need without having to pay out of pocket. Overall, Aveanna Healthcare is in an excellent position to continue to grow its business and provide outstanding care to its patients in the future. The company’s strong financial performance in Q2 indicates that it is on track to have a positive trajectory throughout the rest of the fiscal year. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Aveanna Healthcare. More…

    Total Revenues Net Income Net Margin
    1.83k -219.88 -4.0%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Aveanna Healthcare. More…

    Operations Investing Financing
    -22.07 -12.93 45.55
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Aveanna Healthcare. More…

    Total Assets Total Liabilities Book Value Per Share
    1.74k 1.75k -0.02
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Aveanna Healthcare are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    8.9% -18.7% -5.1%
    FCF Margin ROE ROA
    -1.7% 305.7% -3.4%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we recently conducted an analysis of AVEANNA HEALTHCARE‘s financials. After careful review, we have concluded that AVEANNA HEALTHCARE is a high risk investment in terms of both financial and business aspects. We identified four risk warnings in the income sheet, balance sheet, cashflow statement, and financial journal of AVEANNA HEALTHCARE. To view our detailed report and further assess the potential risks of this investment, register with us today. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • Peers

    The competitive landscape in the home healthcare services industry is heating up, with Aveanna Healthcare Holdings Inc taking on Amedisys Inc, InnovAge Holding Corp, and National Healthcare Corp. All four companies are vying for a piece of the pie in an industry that is expected to grow significantly in the coming years. While each company has its own strengths and weaknesses, it is clear that Aveanna is in a strong position to compete against its rivals.

    – Amedisys Inc ($NASDAQ:AMED)

    Amedisys Inc is a home health care company with a market cap of 3.17B as of 2022. The company has a Return on Equity of 11.56%. Amedisys Inc provides home health and hospice services to patients in the United States. The company offers a variety of services, including skilled nursing, physical therapy, occupational therapy, speech therapy, and home health aides. Amedisys Inc also provides palliative care and hospice services.

    – InnovAge Holding Corp ($NASDAQ:INNV)

    InnovAge Holding Corp is a provider of senior services in the United States. The company has a market cap of 829.66M as of 2022 and a return on equity of -0.87%. The company offers a variety of services to seniors, including home health care, transportation, and meals. The company also has a number of programs designed to help seniors stay healthy and independent, such as exercise and wellness programs.

    – National Healthcare Corp ($NYSEAM:NHC)

    National Healthcare Corporation is a real estate investment trust that invests in senior housing and healthcare properties. As of December 31, 2020, the company owned and operated 245 senior housing and healthcare properties in 29 states and Puerto Rico.


    Aveanna Healthcare reported strong second quarter financial results for the fiscal year 2023, with total revenue increasing by 6.5% and net income soaring by 105.4%. The stock price reacted positively to the news, signalling positive investor sentiment. Investors are likely to be encouraged by the company’s continued strong performance, suggesting potential for further share price appreciation in the future.

    Aveanna Healthcare has also demonstrated its ability to control costs and efficiently manage its operations, suggesting profitability should persist. With this in mind, investors have a good reason to consider investing in Aveanna Healthcare.

    Recent Posts

    Leave a Comment